These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872 [TBL] [Abstract][Full Text] [Related]
8. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache. Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435 [TBL] [Abstract][Full Text] [Related]
9. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Juhasz G; Zsombok T; Jakab B; Nemeth J; Szolcsanyi J; Bagdy G Cephalalgia; 2005 Mar; 25(3):179-83. PubMed ID: 15689192 [TBL] [Abstract][Full Text] [Related]
10. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Bellamy JL; Cady RK; Durham PL Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148 [TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype. Hansen JM; Thomsen LL; Olesen J; Ashina M Neurology; 2008 Sep; 71(11):841-7. PubMed ID: 18779512 [TBL] [Abstract][Full Text] [Related]
13. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Goadsby PJ; Edvinsson L; Ekman R Ann Neurol; 1988 Feb; 23(2):193-6. PubMed ID: 2454066 [TBL] [Abstract][Full Text] [Related]
14. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine. Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487 [TBL] [Abstract][Full Text] [Related]
15. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine. Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383 [TBL] [Abstract][Full Text] [Related]
16. Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders. Sarchielli P; Pini LA; Zanchin G; Alberti A; Maggioni F; Rossi C; Floridi A; Calabresi P Cephalalgia; 2006 Mar; 26(3):257-65. PubMed ID: 16472331 [TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide levels are elevated in patients with sepsis. Joyce CD; Fiscus RR; Wang X; Dries DJ; Morris RC; Prinz RA Surgery; 1990 Dec; 108(6):1097-101. PubMed ID: 2247835 [TBL] [Abstract][Full Text] [Related]
18. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Goadsby PJ; Edvinsson L Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188 [TBL] [Abstract][Full Text] [Related]
19. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028 [TBL] [Abstract][Full Text] [Related]